Clover Health Investments, Corp.
CLOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,569 | $1,420 | $1,784 | $1,549 |
| - Cash | $190 | $189 | $155 | $195 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,379 | $1,231 | $1,629 | $1,355 |
| Revenue | $497 | $478 | $462 | $337 |
| % Growth | 4% | 3.3% | 37.2% | – |
| Gross Profit | $73 | $100 | $109 | $94 |
| % Margin | 14.7% | 20.9% | 23.6% | 27.9% |
| EBITDA | -$24 | -$10 | -$1 | -$21 |
| % Margin | -4.8% | -2.1% | -0.2% | -6.3% |
| Net Income | -$24 | -$11 | -$1 | -$22 |
| % Margin | -4.9% | -2.2% | -0.3% | -6.6% |
| EPS Diluted | -0.048 | -0.021 | -0.003 | -0.045 |
| % Growth | -128.4% | -700% | 94.2% | – |
| Operating Cash Flow | $12 | $5 | -$16 | -$86 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | $11 | $5 | -$16 | -$86 |